Skip to main content
Watch Insiders
ACRVHealthcare

Acrivon Therapeutics Inc (ACRV) Insider Trading

In the last 90 days, 7 Acrivon Therapeutics Inc (ACRV) insiders reported no open-market purchases and 11 sales totaling $74,739. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 22, 2026Mary MillerChief Legal OfficerSale513$1.84$943.92
Oct 5, 2026Mary MillerChief Legal OfficerSale294$1.99$585.06
Aug 25, 2026Peter Blume-JensenPresident and CEOSale14,036$2.21$30,969
Aug 25, 2026Kristina MassonEVP - Business OperationsSale14,036$2.21$30,969
Aug 18, 2026Katharine PetersonChief Accounting OfficerSale101$2.01$203.01
Aug 18, 2026Mary MillerChief Legal OfficerSale185$2.01$371.85
Aug 18, 2026Erick GamelinChief Development OfficerSale400$2.01$804.00
Aug 18, 2026Eric DevroeChief Operating OfficerSale604$2.01$1,214
Aug 18, 2026Peter Blume-JensenPresident and CEOSale1,713$2.01$3,443
Aug 18, 2026Kristina MassonEVP - Business OperationsSale1,713$2.01$3,443
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

ACRV insider trading FAQ

Are ACRV insiders buying or selling?
Over the last 90 days, ACRV insiders were net sellers, reporting $0.00 of open-market purchases and $74,739 of sales.
When was the last ACRV insider purchase?
No open-market insider purchase of Acrivon Therapeutics Inc stock was reported in the last 90 days.
Where does ACRV insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Acrivon Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.